No Decreased Risk of Gastrointestinal Cancers in Users of Metformin in The Netherlands; A Time-Varying Analysis of Metformin Exposure

In conclusion, no decreased risk of GI cancer was found in current metformin users compared with current users of other NIADs. Variations in the exposure definition of metformin use may be one of the explanations of previously found reduced cancer risks in metformin users. Cancer Prev Res; 10(5); 290–7. ©2017 AACR.

Source: Cancer Prevention Research - May 1, 2017 Category: Cancer & Oncology Authors: de Jong, R. G., Burden, A. M., de Kort, S., van Herk-Sukel, M. P., Vissers, P. A., Janssen, P. K., Haak, H. R., Masclee, A. A., de Vries, F., Janssen-Heijnen, M. L. Tags: Research Articles Source Type: research